Pain intensity level on a @-@ numerical rating visual analog scale ( VAS ) , frequency of BTcP throughout the day , onset of relief ( @-@ , @-@ , @-@ , or over @min ) , time required for dose titration , patient satisfaction and adverse effects were assessed at @ , @ , @ , and @days after starting the treatment .